Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide Regimen for Pancreatectomy Complications
NCT03398941Unknown
- Start
- Feb 2018
- Primary completion
- Jan 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial of octreotide in pancreatic fistula (POPF). Primary endpoints: Pancreatic Fistula at 3 weeks, Delayed Gastric Emptying at 3 weeks and 4 more. Status: unknown.
02
Drugs
octreotide
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT03398941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398941.